1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEmerging Infectious Diseases Research is sponsored by National Science Foundation (NSF). Supports cross-disciplinary research on emerging infectious diseases, including development of new therapeutics, diagnostics, and preventive measures.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* Research Experiences for Undergraduates * For Early-Career Researchers * For Postdoctoral Fellows * * Preparing Your Proposal * Submitting Your Proposal * Proposal & Award Policies & Procedures Guide (PAPPG) * How We Make Funding Decisions * Request a Change to Your Award * Proposal & Award Policies & Procedures Guide (PAPPG) * NSF Public Access Repository * Who to Contact With Questions * Artificial Intelligence * Explore All Focus Areas * Facilities and Infrastructure * Updates on NSF Priorities * Our Directorates & Offices * Biological Sciences (BIO) * Computer & Information Science & Engineering (CISE) * Integrative Activities (OIA) * International Science & Engineering (OISE) * Mathematical & Physical Sciences (MPS) * Social, Behavioral & Economic Sciences (SBE) * Technology, Innovation & Partnerships (TIP) * National Center for Science & Engineering Statistics (NCSES) * National Science Board (NSB) # Emerging Infectious Diseases View image credit & caption 3.
Emerging Infectious Diseases The U.S. National Science Foundation supports research on emerging infectious diseases through cross-disciplinary efforts spanning biological, physical and social sciences and engineering.
This research aims to predict, detect and mitigate disease — be it in plants, non-human animals, or humans — by developing new therapeutics, detection methods and preventative measures, safeguarding public health and economic stability.
NSF-supported research on emerging infectious diseases cuts across areas of science and engineering, including understanding the science of transmission, modeling disease spread, and evaluating and mitigating the impact on society.
### Education and workforce development NSF supports the creation of a highly skilled workforce ready to design, implement and manage innovative solutions to understand, track, and mitigate emerging infectious diseases.
### Partnerships and collaboration NSF partners with other federal agencies, industry and nonprofits to advance research on emerging infectious diseases and spurs collaborations among NSF-funded researchers to achieve the interdisciplinarity critical to this area of research.
### Directorate for Biological Sciences") ### Directorate for Computer and Information Science and Engineering") ### Directorate for Mathematical and Physical Sciences") ### Directorate for Technology, Innovation, and Partnerships * Regional Innovation Engines * Pathways to Enable Open-Source Ecosystems") * NSF Innovation Corps (I-Corps™) * America’s Seed Fund, powered by NSF ### Cross-directorate and NSF-wide programs * Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science") * Established Program to Stimulate Competitive Research (EPSCoR)") * Publication date: October 31, 2024 * Last updated: August 27, 2026 Image credits & captions on this page This illustration reveals ultrastructural morphology exhibited by coronaviruses.
Credit: Alissa Eckert/MSMI; Dan Higgins/MAMS A computer-generated illustration demonstrating how the SARS-CoV-2 virus is able to enter human cells through use of its so-called “spike” protein. To infect a cell, the SARS-CoV-2 spike protein (tan) reaches out and grabs the human cell (brown), then pulls the virus (blue) into the cell.
The research was done by a collaboration led by José Onuchic and Paul Whitford at the Center for Theoretical Biological Physics, an NSF Physics Frontiers Center at Rice University, and Northeastern University in partnership with an experimental effort led by Walter Mothes and Wenwei Li at Yale University.
Credit: Mikey Grunst, Yale University At the Next Generation National Advanced Technological Education (ATE) Center of Excellence for Biotechnology and Life Sciences located at the City College of San Francisco in San Francisco, California, instructional materials teach students to use aseptic techniques to manipulate mouse stem cells in culture.
Learn more about all the ATE centers, now in their 25th year and supported by the National Science Foundation, in the ATE Impacts 2018-2019 book. Credit: Credit: Photo from ATE Impacts 2018-2019 Book (https://ateimpacts. net/book) NSF Director Panchanathan traveled to Gandhinagar to represent the United States as Head of Delegation at the G20 Chief Science Advisers' Roundtable, Aug.
27-29. The meeting, under the leadership of Principal Scientific Adviser to the Government of India Ajay Sood, brought together STEM leaders from G20 members and guest countries to consider evidence-informed science advice with respect to the meeting's four agenda topics: 1. Opportunities in One Health for better disease prevention, control and pandemic preparedness.
2. Synergizing global efforts to expand the access to scholarly scientific knowledge. 3.
Diversity, equity, inclusion and accessibility in science and technology ecosystem. 4. Creating an inclusive, continuous, and action-oriented Global Science Advice Mechanism.
Credit: U.S. Consulate General Mumbai New grants from NSF and other agencies are supporting research on infectious disease transmission. Credit: CDC/ Michael L. Levin, PhD One of six network core switches on the Frontera supercomputer at TACC that route communication between the server nodes.
"String Theory," by Peter Coneski, Jessica Nash and Mark Schoenfisch. These electrospun polymer microfibers were prepared in chemist Mark Schoenfisch's lab, where Coneski and his colleagues are looking for ways to make antibacterial and antithrombotic medical device coatings from polymer microfibers that are capable of controlled release of nitric oxide.
Coneski is a doctoral student, Nash is an undergraduate, and Schoenfisch is a professor of chemistry, all in the Department of Chemistry in the College of Arts and Sciences at the University of North Carolina at Chapel Hill. This image is from the second annual scientific art competition held by the Chapel Hill Analytical and Nanofabrication Laboratory (CHANL).
CHANL is home to a series of electron microscopes; an X-ray photoelectron spectrometer; a cleanroom with photolithography, deposition and etching systems; and many other powerful imaging tools and equipment. The scientific art competition takes place in the spring and is open to anyone on campus.
Entries this year came from students and faculty across the university, including many in pharmacy, biomedical engineering, medicine, computer science, studio art, physics and astronomy, and chemistry. Additional information on the competition and CHANL can be found on the CHANL website.
Credit: Peter Coneski, Jessica Nash and Mark Schoenfisch NSF Small Business Innovation Research grant awardee Savage Medical is developing novel, minimally invasive tools and procedures for colorectal tumor removal. Researchers at the University of California, San Diego, working in the lab of Assistant Professor Justin Meyer, discovered evidence of a new path of evolution for the lambda virus, which infects bacteria but not humans.
More about this image Researchers at the University of California, San Diego (UC-San Diego), and colleagues have discovered evidence of a new path of evolution and with it a deeper understanding of how quickly organisms such as viruses can adapt to their environment.
UC-San Diego biologists conducted a series of experiments with a bacterial virus and found that it could infect "normal" hosts, as expected, but also -- through a process previously unseen in evolution -- acquired an ability to infect new host targets.
The researchers say their findings, which address longstanding mysteries of how genes acquire new functions and how mutations arise to ease transmission from one host to another, could be applied to investigations of viral diseases such as Zika, Ebola and bird flu.
"This research shows us that viruses are much more adaptable than previously anticipated," said Justin Meyer, a UC San Diego biological sciences assistant professor and senior author of a published paper about the research. "By learning how viruses achieve evolutionary flexibility, we have new insight into how to set up road blocks to stop the emergence of new diseases."
This research was funded in part by a National Science Foundation Graduate Research Fellowship (grant DGE 14-24871). To learn more about this research, see the NSF News From the Field story Virus found to adapt through newly discovered path of evolution. Credit: University of California, San Diego * Our Directorates & Offices * Budget, Performance & Financial Reporting Let us know how we're doing, and how we can make NSF.
gov better for you. This survey is for feedback on the **NSF website experience only**. If you have questions or comments about NSF's programs, offices, staff or publications, please visit our Contact Us page.
A red asterisk (*) indicates a required field. Thank you for your valuable feedback. How can we improve this page?
2500 characters allowed The NSF website design team may want to learn more about your experience. If it is okay for us to contact you, please provide your email. Your email address is used solely to communicate with you about your feedback in order to improve the NSF website.
NSF does not use it for any other purpose or provide it to any third parties. _A federal agency may not conduct or sponsor a collection of information unless it displays a currently valid OMB control number; the number for this is 3145-0215. _ Privacy Act Statement for Design Research An official form of the United States government.
Provided by Touchpoints OMB Approval #3145-0215 · Expiration Date 08/31/2026
According to the current listing, eligibility includes: Nonprofit organizations, including Canadian entities, engaged in research and development. Confirm the full requirements in the official notice before applying.
Emerging Infectious Diseases Research is funded by National Science Foundation (NSF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
TCUP lists eight funding tracks and roughly $10.3M a year, but the October 14, 2026 deadline applies to only three of them — CHAI, Pre-TI, and TCUP Partnerships — and each carries a restriction that disqualifies most applicants. Here is the track-by-track math.
Read articleNSF 26-513 makes roughly $100 million available for up to 10 State and Regional AI Infrastructure Hubs at $4M to $12M each over five years. One award per state or multi-state region. One proposal per organization. And NSF is not buying you GPUs — it funds the coordination, the workforce and the faculty training, while the compute has to come from partners you have to already have.
Read articleAs of September 12, NSF had obligated $6.3 billion across 6,200 grants versus $8.1 billion and 8,600 last year. AHRQ has made 61 awards. Judge Allison Burroughs ordered the government to report by September 28 on whether IES will obligate $180 million before it expires. Here is what actually happens to the money on October 1 — and what it means for your FY2027 application.
Read article